Posted by Michael Wonder on 23 Jun 2021
Price disclosure 2021 October cycle outcomes summary
23 June 2021 - The summary of price disclosure price reductions for the 2021 October cycle has now been published.
The following medicines are scheduled to incur a 30% price reduction:
- Azacitidine
- Imatinib mesylate
- Sildenafil citrate
- Tobramycin
